Background: Due to the substantial increase in beam-on time of high energy intensity-modulated radiotherapy (>10 MV) techniques to deliver the same target dose compared to conventional treatment techniques, an increased dose of scatter radiation, including neutrons, is delivered to the patient. As a consequence, an increase in second malignancies may be expected in the future with the application of intensity-modulated radiotherapy. It is commonly assumed that the neutron dose equivalent scales with the number of monitor units.Methods: Measurements of neutron dose equivalent were performed for an open and an intensity-modulated field at four positions: inside and outside of the treatment field at 0.2 cm and 15 cm depth, respectively.Results: It was shown that the neutron dose equivalent, which a patient receives during an intensity-modulated radiotherapy treatment, does not scale with the ratio of applied monitor units relative to an open field irradiation. Outside the treatment volume at larger depth 35% less neutron dose equivalent is delivered than expected.Conclusions: The predicted increase of second cancer induction rates from intensity-modulated treatment techniques can be overestimated when the neutron dose is simply scaled with monitor units. © 2012 Hälg et al.; licensee BioMed Central Ltd.
CITATION STYLE
Hälg, R. A., Besserer, J., Boschung, M., Mayer, S., & Schneider, U. (2012). Monitor units are not predictive of neutron dose for high-energy IMRT. Radiation Oncology, 7(1). https://doi.org/10.1186/1748-717X-7-138
Mendeley helps you to discover research relevant for your work.